RxDoctor Payments Data

Amber Rogers, APRN

Family · Kearney, NENPI 1114561909

Payments from drug & device makers

$1,178in general payments, 2019–2025

Across 77 payments — averaging $15.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$226
  • Lilly USA, LLC$108
  • Astellas Pharma US Inc$106
  • Otsuka America Pharmaceutical, Inc.$91
  • Amgen$64
  • AbbVie$62
  • plus $520 from 19 others

What the payments were for

  • Food & beverage$1,16699%
  • Education$121%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,178 in reported general payments places this provider in the 75th percentile of 809 family providers in Nebraska.

See all family providers in Nebraska

Medicare billing

Part B allowed, 2024
$14,482
Medicare patients
56
Services billed
363

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin14$18,784
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog11$7,152
SynthroidLevothyroxine Sodium15$638
Rosuvastatin Calcium51$586
Levothyroxine Sodium49$466
Lisinopril36$374
Omeprazole31$362
Amlodipine Besylate58$351
Atorvastatin Calcium57$346
Potassium Chloride22$247
Gabapentin21$173
Metformin Hcl ErMetformin Hcl35$168
Trazodone Hcl15$143
Escitalopram Oxalate16$139
Metformin Hcl28$137

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$47$18,78414 claims
AbbVieSynthroid$62$63815 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 809 family providers in Nebraska.

Other family in Kearney

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →